Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being ...

SAN FRANCISCO, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- The National Psoriasis Foundation (NPF) is ...

A Maui Derm 2026 session explored advancements in pediatric dermatology, emphasizing precision medicine and targeted therapies for children.

Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...

Arcutis Biotherapeutics and Kowa Pharmaceuticals are cutting ties on their U.S. marketing partnership around Arcutis’ Zoryve ...

Learn to communicate confidently about the condition, manage self-consciousness, and define yourself beyond your skin for ...

Winter in Bangladesh arrives quietly, but its impact on the skin is immediate. As humidity levels drop and cold, dry air ...

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

Patient advocate Howard Chang’s visit to Boehringer Ingelheim’s biopharmaceutical facility revealed both how biologic ...

Single-center study finds durable, steroid-free remission, especially in ulcerative coliti ...

A study published in Nutrition Reviews in November 2025 found evidence linking oral probiotics and synbiotics to improvements in atopic dermatitis (AD) symptoms. However, research for other skin ...

BRITS have been urged to be vigilant after a surge in cases of a highly infectious Victorian disease that can trigger ...